NNPA NEWSWIRE — The administration unveiled a proposed framework for agencies to exercise march-in rights on taxpayer-funded drugs and inventions. According to the White House, this...
Addressing longstanding concerns about corporate interests influencing healthcare, the administration announced that it’s cracking down on price gouging by Big Pharma.
